National Comprehensive Cancer Network



About NCCN

Central Nervous System Cancers Panel - Disclosures as of 2/13/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Mario Ammirati, MD, MBA

None

None

None

None

3/29/2012

Philip J. Bierman, MD

None

None

None

None

5/1/2013

Henry Brem, MD

None

None

None

None

11/6/2013

Nicholas Butowski, MD

None

None

None

None

8/17/2013

Marc C. Chamberlain, MD

NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas

Enzon Pharmaceuticals;
Exelixis Inc.;
Genentech, Inc.;
Schering-Plough Corporation

None

None

11/5/2013

Lisa M. DeAngelis, MD

None

Genentech, Inc.

None

None

1/8/2014

Robert A. Fenstermaker, MD

None

None

None

None

8/28/2013

Allan Friedman, MD

None

None

None

None

9/26/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Mark R. Gilbert, MD

RTOG Trial

Abbott Laboratories;
Genentech, Inc.;
Merck & Co., Inc.;
Pfizer Inc.;
Schering-Plough Corporation

None

None

8/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Deneen Hesser, MSHSA, RN, OCN

None

None

None

None

11/8/2013

Maria Ho, PhD

None

None

None

None

8/14/2013

Matthias Holdhoff, MD, PhD

None

None

None

None

12/6/2013

Larry Junck, MD

None

None

None

None

10/21/2013

Gerald P. Linette, MD, PhD

None

Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline

None

None

7/28/2011

Jay S. Loeffler, MD

None

None

None

None

8/20/2013

Moshe H. Maor, MD

None

None

None

None

8/24/2012

Joan S. McClure, MS

None

None

None

None

8/13/2013

Nicole McMillian, MS

None

None

None

None

3/9/2014

L. Madison Michael, II, MD

None

None

None

None

7/13/2011

Paul L. Moots, MD

None

None

None

None

11/8/2013

Tara Morrison, MD, FRCPC

None

Merck & Co., Inc.

None

None

10/1/2012

Maciej M. Mrugala, MD, PhD, MPH

None

Enzon Pharmaceuticals;
Schering-Plough Corporation

None

None

11/24/2009

Louis Burt Nabors, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Merck KGaA;
Transmolecular

Merck KGaA

None

None

3/3/2013

Herbert B. Newton, MD

None

Eisai Inc.;
UCB Pharma;
Schering-Plough Corporation

None

None

11/5/2013

Jana Portnow, MD

None

None

None

None

12/5/2013

Jeffrey J. Raizer, MD

None

Enzon Pharmaceuticals;
Genentech, Inc.;
Merck & Co., Inc.;
Merck & Co., Inc.;
Geron

None

None

11/6/2013

Lawrence Recht, MD

Genentech, Inc.;
Celtic Pharmaceuticals

Genentech, Inc.

None

None

2/27/2013

Dennis C. Shrieve, MD, PhD

None

None

None

None

2/26/2013

Allen K. Sills, MD

None

Merck & Co., Inc.

None

None

9/26/2013

Nam Tran, MD, PhD

None

None

None

None

11/6/2013

Frank D. Vrionis, MD, MPH, PhD

Globus;
Synthes

Florida Board of Medicine;
Southeastern Brain Tumor Association

None

Orthofix

11/13/2012

Patrick Yung Wen, MD

None

Genentech, Inc.

None

None

6/3/2013